GenEdit Tag

GenEdit Announces Series A Financing and Provides Research Update at TIDES 2021

September 23, 2021

GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery | Business Wire

December 11, 2019

Biotechnology Company GenEdit Raises $8,5M In A New Funding Round Led By DCVC And Sequoia Capital – Tech Company News

February 16, 2019

Gold nanoparticles effectively deliver CRISPR to mouse models of DMD | Fierce Biotech

October 5, 2017

© Blue Bear Ventures

Email Address

First Name Last Name